152 related articles for article (PubMed ID: 12716283)
21. Naloxone attenuates drinking behavior in a schizophrenic patient displaying self-induced water intoxication.
Nishikawa T; Tsuda A; Tanaka M; Nishikawa M; Koga I; Uchida Y
Clin Neuropharmacol; 1992 Aug; 15(4):310-4. PubMed ID: 1516076
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia.
Buckley PF; Goldstein JM; Emsley RA
Schizophr Res; 2004 Feb; 66(2-3):143-50. PubMed ID: 15061246
[TBL] [Abstract][Full Text] [Related]
23. Attentional improvement following quetiapine fumarate treatment in schizophrenia.
Sax KW; Strakowski SM; Keck PE
Schizophr Res; 1998 Oct; 33(3):151-5. PubMed ID: 9789907
[TBL] [Abstract][Full Text] [Related]
24. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
Arvanitis LA; Miller BG
Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of polydipsia, water intoxication, and delusional jealousy in an alcohol dependent patient with clozapine.
Margetić B; Aukst-Margetić B; Zarković-Palijan T
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1347-9. PubMed ID: 16600455
[TBL] [Abstract][Full Text] [Related]
26. Naloxone attenuates drinking behavior in psychiatric patients displaying self-induced water intoxication.
Nishikawa T; Tsuda A; Tanaka M; Nishikawa M; Koga I; Uchida Y
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):149-53. PubMed ID: 8115669
[TBL] [Abstract][Full Text] [Related]
27. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.
Purdon SE; Malla A; Labelle A; Lit W
J Psychiatry Neurosci; 2001 Mar; 26(2):137-49. PubMed ID: 11291531
[TBL] [Abstract][Full Text] [Related]
28. Neuropsychological manifestations of hyponatremia in chronic schizophrenic patients with the syndrome of psychosis, intermittent hyponatremia and polydipsia (PIP).
Shutty MS; Briscoe L; Sautter S; Leadbetter RA
Schizophr Res; 1993 Aug; 10(2):125-30. PubMed ID: 8398944
[TBL] [Abstract][Full Text] [Related]
29. Targeting cognition in schizophrenia research: from etiology to treatment.
Goldberg TE; Gomar JJ
Am J Psychiatry; 2009 Jun; 166(6):631-4. PubMed ID: 19487396
[No Abstract] [Full Text] [Related]
30. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
Suzuki T; Uchida H; Watanabe K; Nomura K; Takeuchi H; Tomita M; Tsunoda K; Nio S; Den R; Manki H; Tanabe A; Yagi G; Kashima H
Psychopharmacology (Berl); 2007 Dec; 195(2):285-95. PubMed ID: 17701027
[TBL] [Abstract][Full Text] [Related]
31. A case of tardive dystonia successfully managed with quetiapine.
Sasaki Y; Kusumi I; Koyama T
J Clin Psychiatry; 2004 Apr; 65(4):583-4. PubMed ID: 15119928
[No Abstract] [Full Text] [Related]
32. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
[TBL] [Abstract][Full Text] [Related]
33. Granulocytopenia with clozapine and quetiapine.
Diaz P; Hogan TP
Am J Psychiatry; 2001 Apr; 158(4):651. PubMed ID: 11282709
[No Abstract] [Full Text] [Related]
34. Clozapine treatment in polydipsia and intermittent hyponatremia.
Spears NM; Leadbetter RA; Shutty MS
J Clin Psychiatry; 1996 Mar; 57(3):123-8. PubMed ID: 8617697
[TBL] [Abstract][Full Text] [Related]
35. Quetiapine--efficacy in different domains.
Sharma T
Eur Neuropsychopharmacol; 2001 Oct; 11 Suppl 4():S385-90. PubMed ID: 11587885
[TBL] [Abstract][Full Text] [Related]
36. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia.
Copolov DL; Link CG; Kowalcyk B
Psychol Med; 2000 Jan; 30(1):95-105. PubMed ID: 10722180
[TBL] [Abstract][Full Text] [Related]
37. High degree of tolerability for monotherapy with high doses of quetiapine: a case report.
Bobes J; Garcia-Portilla MP; Saiz PA; Bascaran MT; Bousoño M; Arango C
J Clin Psychiatry; 2002 Nov; 63(11):1048-9. PubMed ID: 12469690
[No Abstract] [Full Text] [Related]
38. The consulting psychiatrist and the polydipsia-hyponatremia syndrome in schizophrenia.
Vieweg V; Pandurangi A; Levenson J; Silverman J
Int J Psychiatry Med; 1994; 24(4):275-303. PubMed ID: 7737786
[TBL] [Abstract][Full Text] [Related]
39. Polydipsia and hyponatremia.
Liberman RP; Marshall BD
Hosp Community Psychiatry; 1993 Feb; 44(2):184; author reply 185-6. PubMed ID: 8432507
[No Abstract] [Full Text] [Related]
40. Cataracts and quetiapine.
Valibhai F; Phan NB; Still DJ; True J
Am J Psychiatry; 2001 Jun; 158(6):966. PubMed ID: 11384916
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
